Anavex Life Sciences
AVXL
$3.44
Share price
1.47%
Change (1 day)
-57.74%
Change (1 year)
Categories
Anavex Life Sciences (AVXL) Fails to deliver data
Key failure to deliver metrics for Anavex Life Sciences :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.18 M
- Last 3 months FTD volume: $10.14 M
- Last year FTD volume: $26.78 M
Failures to deliver for Anavex Life Sciences (AVXL) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Anavex Life Sciences (AVXL) - since 2015
Volume in USD (price x number of shares), data since 2015Anavex Life Sciences (AVXL) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $9.43 M | -58.53% |
| 2023 | $22.76 M | -19.49% |
| 2022 | $28.27 M | -32.83% |
| 2021 | $42.09 M | 434.41% |
| 2020 | $7.87 M | 213.26% |
| 2019 | $2.51 M | -0.26% |
| 2018 | $2.52 M | -60.88% |
| 2017 | $6.44 M | -80.98% |
| 2016 | $33.88 M | 13.07% |
| 2015 | $29.96 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | $0.58 M | $3.53 M | 🇺🇸 USA |
 Corcept Therapeutics
CORT | $11.02 M | $17.75 M | 🇺🇸 USA |
 Palatin Technologies PTN | $1.01 M | $1.27 M | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.45 M | $1.95 M | 🇺🇸 USA |